survival rate of patients suffering from gastric adenocarcinoma of yazd city

Authors

a akhavan shahid ramezanzadeh ridiotherapy center, shahid sadughi university of medical sciences, iran -, [email protected]; shahid ramezanzadeh ridiotherapy center, shahid sadughi university of medical sciences, iran -, [email protected]

n bashardoust department of statistics, faculty of medicine, isfahan university of medical sciences, iran

m moghimi department of pathology, faculty of medicine, shahid sadughi university of medical sciences, iran

a seifadini department of pathology, faculty of medicine, shahid sadughi university of medical sciences, iran

abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Characteristics and Survival Rate of Patients with Gastric and Gastroesophageal Junction Adenocarcinoma in Yazd, Iran

Abstract Background:Gastric cancer is the leading cause of cancer deaths in Iran. Treatment for gastric adenocarcinoma varies worldwide. The aim of this study is to evaluate characteristics and survival rate of gastric and gastroesophageal junction adenocarcinoma in Yazd, Iran. Methods: This study was conducted on 53 patients with gastric or gastroesophageal junction adenocarcioma who referred ...

full text

characteristics and survival rate of patients with gastric and gastroesophageal junction adenocarcinoma in yazd, iran

background: gastric cancer is the leading cause of cancer deaths in iran. treatment for gastric adenocarcinoma varies worldwide. the aim of this study is to evaluate char- acteristics and survival rate of gastric and gastroesophageal junction adenocarcinoma in yazd, iran. methods: this study was conducted on 53 patients with gastric or gastroesophageal junction adenocarcioma who referred to sha...

full text

HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma

Gastric adenocarcinoma is the second leading cause of death due to cancer in the world and in advanced stages the prognosis is poor with current therapies. Over-expression of HER-2/neu has been seen in several cancers such as gastric cancer and its expression is associated with poor prognosis. The aim of this study is to evaluate the over-expression of HER-2/neu in gastric biopsy samples of pat...

full text

Five-year Survival Rate for Gastric Cancer in Yazd Province, Central Iran, from 2001 to 2008

BACKGROUND The number of patients with gastric cancer is growing worldwide. In Iran (in 2009) of 74067 new cases of cancer, 6886 were diagnosed as having gastric cancer. This study was conducted to investigate 5-year survival rate for gastric cancer in Yazd province, central Iran. METHODS In this descriptive study, the medical records of patients with gastric cancer were collected from the arch...

full text

Survival Rate of Patients with Stomach Cancer and its Effective Factors in Yazd Province

Introduction: Cancers are the second cause of death in the world after cardiovascular diseases. Cancer of the stomach is one of the most important forms of cancer worldwide. It is the fourth most common form of cancer and the second most common cause of death in the world. There is a wide variation in the survival of gastric cancer among and even within countries. In this study we seek to inves...

full text

her-2/neu marker examination using immunohistochemical method in patients suffering from gastric adenocarcinoma

gastric adenocarcinoma is the second leading cause of death due to cancer in the world and in advanced stages the prognosis is poor with current therapies. over-expression of her-2/neu has been seen in several cancers such as gastric cancer and its expression is associated with poor prognosis. the aim of this study is to evaluate the over-expression of her-2/neu in gastric biopsy samples of pat...

full text

My Resources

Save resource for easier access later


Journal title:
trauma monthly

جلد ۲۰۱۶، شماره ۱۱، صفحات ۳۹-۴۴

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023